121 related articles for article (PubMed ID: 23225332)
1. Analysis of 20 genes at chromosome band 12q13: RACGAP1 and MCRS1 overexpression in nonsmall-cell lung cancer.
Liang Y; Liu M; Wang P; Ding X; Cao Y
Genes Chromosomes Cancer; 2013 Mar; 52(3):305-15. PubMed ID: 23225332
[TBL] [Abstract][Full Text] [Related]
2. The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway.
Liu M; Zhou K; Huang Y; Cao Y
J Exp Clin Cancer Res; 2015 Oct; 34():121. PubMed ID: 26467212
[TBL] [Abstract][Full Text] [Related]
3. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
[TBL] [Abstract][Full Text] [Related]
4. Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1.
Liu Q; Zhao XY; Bai RZ; Liang SF; Nie CL; Yuan Z; Wang CT; Wu Y; Chen LJ; Wei YQ
Oncol Rep; 2009 Nov; 22(5):1069-75. PubMed ID: 19787223
[TBL] [Abstract][Full Text] [Related]
5. The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression.
Ezponda T; Pajares MJ; Agorreta J; Echeveste JI; López-Picazo JM; Torre W; Pio R; Montuenga LM
Clin Cancer Res; 2010 Aug; 16(16):4113-25. PubMed ID: 20682707
[TBL] [Abstract][Full Text] [Related]
6. [Overexpression of miR-21 promotes proliferation and reduces apoptosis in non-small cell lung cancer].
Lan H; Lin CY; Yuan HY; Xiong B
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):742-6. PubMed ID: 22335905
[TBL] [Abstract][Full Text] [Related]
7. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
[TBL] [Abstract][Full Text] [Related]
8. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle protein cyclin Y is associated with human non-small-cell lung cancer proliferation and tumorigenesis.
Yue W; Zhao X; Zhang L; Xu S; Liu Z; Ma L; Jia W; Qian Z; Zhang C; Wang Y; Yang X
Clin Lung Cancer; 2011 Jan; 12(1):43-50. PubMed ID: 21273179
[TBL] [Abstract][Full Text] [Related]
11. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer].
Yang Q; Zhu RQ; Fang Z; Xia D; Diao LM; Liu MQ
Ai Zheng; 2005 Mar; 24(3):321-6. PubMed ID: 15757534
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinoma.
Wang SM; Ooi LL; Hui KM
Clin Cancer Res; 2011 Sep; 17(18):6040-51. PubMed ID: 21825042
[TBL] [Abstract][Full Text] [Related]
13. Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer.
Milde-Langosch K; Karn T; Müller V; Witzel I; Rody A; Schmidt M; Wirtz RM
Breast Cancer Res Treat; 2013 Jan; 137(1):57-67. PubMed ID: 23135572
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of polo-like kinase 1 and its clinical significance in human non-small cell lung cancer.
Wang ZX; Xue D; Liu ZL; Lu BB; Bian HB; Pan X; Yin YM
Int J Biochem Cell Biol; 2012 Jan; 44(1):200-10. PubMed ID: 22064247
[TBL] [Abstract][Full Text] [Related]
15. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
Sun SY; Yue P; Hong WK; Lotan R
Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
[TBL] [Abstract][Full Text] [Related]
16. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.
Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC
Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235
[TBL] [Abstract][Full Text] [Related]
17. [Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer].
Anedchenko EA; Dmitriev AA; Krasnov GS; Kondrat'eva TT; Kopantsev EP; Vinogradova TV; Zinov'eva MV; Zborovskaia IB; Polotskiĭ BE; Sakharova OV; Kashuba VI; Zabarovskiĭ ER; Senchenko VN
Mol Biol (Mosk); 2008; 42(6):965-76. PubMed ID: 19140316
[TBL] [Abstract][Full Text] [Related]
18. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.
Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS
Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136
[TBL] [Abstract][Full Text] [Related]
19. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
[TBL] [Abstract][Full Text] [Related]
20. Deleted in pancreatic carcinoma locus 4/Smad4 participates in the regulation of apoptosis by affecting the Bcl-2/Bax balance in non-small cell lung cancer.
Ke Z; Zhang X; Ma L; Wang L
Hum Pathol; 2008 Oct; 39(10):1438-45. PubMed ID: 18620728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
